The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication

Virology

Volumn 263, Issue 2, 1999, Pages 460-470

  Prabhu, S ^a   Lobelle Rich, P A ^a   Levy, L S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENHANCER REGION; FELINE LEUKEMIA VIRUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIROGENESIS; VIRUS REPLICATION;

FELIDAE; FELINE LEUKEMIA VIRUS; RNA VIRUSES;

EID: 0033604294     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9974     Document Type: Article

References (40)

1. Athas G. B., Choi B., Prabhu S., Lobelle-Rich P. A., Levy L. S. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology. 214:1995a;431-438.
2. Athas G. B., Lobelle-Rich P., Levy L. S. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J. Virol. 69:1995b;3324-3332.
3. Athas G. B., Starkey C. R., Levy L. S. Retroviral determinants of leukemogenesis. Crit. Rev. Oncog. 5:1994;169-199.
4. Bonham L., Lobelle-Rich P. A., Henderson L. A., Levy L. S. Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells. J. Virol. 61:1987;3072-3081.
5. Boomer S., Gasper P., Whalen L. R., Overbaugh J. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A. Virology. 204:1994;805-810.
6. Burger S. R., Zutter M. M., Sturgill-Koszycki S., Santoro S. A. Induced cell surface expression of functional alpha2beta1 integrin during megakaryocytic differentiation of K562 leukemic cells. Exp. Cell Res. 202:1992;28-35.
7. Casey J. W., Roach A., Mullins J. I., Burck K. B., Nicolson M. O., Gardner M. B., Davidson N. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc. Natl. Acad. Sci. USA. 78:1981;7778-7782.
8. Chen H., Yoshimura F. K. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities. J. Virol. 68:1994;3308-3316.
9. Chen H., Yoshimura F. K. Spacing between the enhancer and promoter of the long terminal repeat of a murine leukaemia retrovirus is required for transcriptional activation in T cells. J. Gen. Virol. 79:1998;1101-1104.
10. Coffin J. M. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:1992;143-164.
11. Courchamp F., Suppo C., Fromont E., Bouloux C. Dynamics of two feline retroviruses (FIV and FeLV) within one population of cats. Proc. R. Soc. Lond. B Biol. Sci. 264:1997;785-794.
12. DiFronzo N. L., Holland C. A. Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity. J. Virol. 73:1999;234-241.
13. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
14. Domingo E., Martinez-Salas E., Sobrino F., de la Torre J. C., Portela A., Ortin J., Lopez-Galindez C., Perez-Brena P., Villanueva N., Najera R. et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: Biological relevance - a review. Gene. 40:1985;1-8.
15. Donahue P. R., Hoover E. A., Beltz G. A., Riedel N., Hirsch V. M., Overbaugh J., Mullins J. I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:1988;722-731.
16. Feghali C. A., Bost K. L., Boulware D. W., Levy L. S. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity. 17:1994;309-318.
17. Fromont E., Pontier D., Langlais M. Dynamics of a feline retrovirus (FeLV) in host populations with variable spatial structure. Proc. R. Soc. Lond. B Biol. Sci. 265:1998;1097-1104.
18. Fulton R., Plumb M., Shield L., Neil J. C. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J. Virol. 64:1990;1675-1682.
19. Golemis E. A., Speck N. A., Hopkins N. Alignment of U3 region sequences of mammalian type C retroviruses: Identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:1990;534-542.
20. Hoover E. A., Mullins J. I. Feline leukemia virus infection and diseases. J. Am. Vet. Med. Assoc. 199:1991;1287-1297.
21. Horton R. M., Cai Z. L., Ho S. N., Pease L. R. Gene splicing by overlap extension: Tailor-made genes using the polymerase chain reaction. BioTechniques. 8:1990;528-535.
22. Katz R. A., Skalka A. M. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:1990;409-445.
23. Levesque K. S., Bonham L., Levy L. S. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J. Virol. 64:1990;3455-3462.
24. Lozzio B. B., Lozzio C. B., Bamberger E. G., Feliu A. S. A multipotential leukemia cell line (K562) of human origin. Proc. Soc. Exp. Biol. Med. 166:1981;546-550.
25. Mansky L. M. Retrovirus mutation rates and their role in genetic variation. J. Gen. Virol. 79:1998;1337-1345.
26. Matsumoto Y., Momoi Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology. 189:1992;745-749.
27. McDougall A. S., Terry A., Tzavaras T., Cheney C., Rojko J., Neil J. C. Defective endogenous proviruses are expressed in feline lymphoid cells: Evidence for a role in natural resistance to subgroup B feline leukemia viruses. J. Virol. 68:1994;2151-2160.
28. Mullins J. I., Casey J. W., Nicolson M. O., Burck K. B., Davidson N. Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line. J. Virol. 38:1981;688-703.
29. Neil J. C., Fulton R., Rigby M., Stewart M. Feline leukaemia virus: Generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol. 171:1991;67-93.
30. Nishigaki K., Endo Y., Matsumoto Y., Watari T., Goitsuka R., Tsujimoto H., Hasegata A. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses. Leukemia. 11:1997;189-192.
31. Pantginis J., Beaty R. M., Levy L. S., Lenz J. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity. J. Virol. 71:1997;9786-9791.
32. Plumb M., Fulton R., Breimer L., Stewart M., Willison K., Neil J. C. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines. J. Virol. 65:1991;1991-1999.
33. Rezanka L. J., Rojko J. L., Neil J. C. Feline leukemia virus: Pathogenesis of neoplastic disease. Cancer Invest. 10:1992;371-389.
34. Rhodes D., Klug A. Helical periodicity of DNA determined by enzyme digestion. Nature. 286:1980;573-578.
35. Rohn J. L., Overbaugh J. In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. Virology. 206:1995;661-665.
36. Rojko J. L., Kociba G. J., Abkowitz J. L., Hamilton K. L., Hardy W. D. Jr., Ihle J. N., O'Brien S. J. Feline lymphomas: Immunological and cytochemical characterization. Cancer Res. 49:1989;345-351.
37. Roy-Burman P. Endogenous env elements: Partners in generation of pathogenic feline leukemia viruses. Virus Genes. 11:1996;147-161.
38. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., Neil J. C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: Patterns of proviral insertion and gene rearrangement. J. Virol. 68:1994;8296-8303.
39. Tullius T. D., Dombroski B. A. Iron(II) EDTA used to measure the helical twist along any DNA molecule. Science. 230:1985;679-681.
40. Yoshimura F. K., Cankovic M., Smeltz R., Ibrahim S. Identification of nucleotide sequences that regulate transcription of the MCF13 murine leukemia virus long terminal repeat in activated T cells. J. Virol. 71:1997;2572-2576.